By Economic Times – WHO welcomes India’s COVID-19 vaccine approval SynopsisAccording to Khetrapal, the use of vaccine in “priortised population” as well as implementation of other public health measures will be important in reducing the impact of the pandemic.WHO welcomed the first emergency use authorization given to COVID-19 vaccine in the WHO South-East Asia Region. The World Health Organisation on Sunday welcomed India’s decision giving emergency use authorisation to COVID-19 vaccines, saying it will help “intensify” and “strengthen” its fight against the ongoing pandemic. India’s drugs regulator has approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.
It paves the way for the roll out of at least two vaccines in the country in the coming days.
“WHO welcomes the first emergency use authorization given to COVID-19 vaccine in the WHO South-East Asia Region. This decision taken today by India will help intensify and strengthen the fight against COVID-19 pandemic in the Region,” said Dr Poonam Khetrapal Singh, the regional director, WHO South-East Asia Region.
According to Khetrapal, the use of vaccine in “priortised population” as well as implementation of other public health measures will be important in reducing the impact of the pandemic.
“The use of vaccine in prioritised populations, along with continued implementation of other public health measures and community participation will be important in reducing the impact of COVID-19,” she added.
Prime Minister Narendra Modi termed the approval a decisive turning point in the country’s fight against coronavirus.
India’s COVID-19 tally of cases climbed to 1,03,23,965 with 18,177 new cases in a day, while 99,27,310 people have recuperated so far pushing the national recovery rate to 96.15 per cent on Sunday, according to the Union Health Ministry data.
There are 2,47,220 active cases of coronavirus in the country which comprise 2.39 per cent of the total caseload, the data stated.
The death toll climbed to 1,49,435 with the novel coronavirus virus claiming 217 lives in a span of 24 hours in the country, the data updated at 8 am showed.
India approves Covid-19 vaccines: Here’s all you need to knowTwo for emergency useIndia has approved emergency use of two vaccines for coronavirus on Sunday. Developed by AstraZeneca-Oxford University and India’s Bharat Biotech, the approval is set to pave the way for one of the biggest vaccination drives.
(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)Download The Economic Times News App to get Daily Market Updates & Live Business News.2 Comments on this StoryM.L.GUPTA9 hours agoIndia has the potential and can make great deeds if the Leadership thinks positive and acts encouraging. For great leadership, Prime Minister Narendra Modi deserves all the applaud. The previous regime created the culture of corruption even in the nation’s scientific establishment causing infamy even for the top scientists of ISRO. Had Narendra Modi not been the driver, our scientists would still be importing masks and PPE and other kits at inflated costs like those paid for the CWG rates of Rs 945 for a toilet roll. The scientists deserve our praise. We expect more from them. As a public servant I know our capabilities in spite of all the limitations, including the biggest obstacle called the Internal Finance Wing misbehaving under the Finance Secretary and Finance Minister patronage of those days.Rajkumar Almale11 hours agoA proud moment for every Indian. With all sincere efforts, India achieved this great milestone in its journey to fight against Covid-19. A big thanks to all those who are part of this great achievement.
For more details, please visit http://gestyy.com/ethGWD